Mucosal immunization with a genetically engineered pertussis toxin S1 fragment-cholera toxin subunit B chimeric protein

"As soon as it's trying to be persuasive, my skepticism kicks in": A qualitative study to co-design vaccine communication strategies with vaccine hesitant adults in Canada.

Human vaccines & immunotherapeutics·2026

Safety and immunogenicity of one or two doses of the rVSVΔG-ZEBOV-GP Ebola virus vaccine in adults and adolescents living with HIV: a phase 2, multicentre, double-blind, randomised, placebo-controlled trial.

The lancet. HIV·2026

A controlled human infection model for symptomatic pertussis in North America using the pertactin-producing clinical isolate D420.

medRxiv : the preprint server for health sciences·2026

Epidemiology and severity of pediatric influenza hospitalizations before and during the COVID-19 pandemic: a surveillance study of the Canadian immunization monitoring program (IMPACT), 2012-2023.

Lancet regional health. Americas·2026

Safety and immunogenicity of a booster dose of COVAC-2, a Sepivac SWE™ adjuvanted SARS-CoV-2 recombinant protein vaccine in previously vaccinated healthy adults; a randomized controlled multicentre trial.

Human vaccines & immunotherapeutics·2026

Relative efficacy, safety, and immunogenicity analysis of two doses versus one dose of recombinant coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomized, double blinded phase 3 trial.

Vaccine·2026

What goes around comes around: updates in the study of Coxiella burnetii lipopolysaccharide phase variation.

Infection and immunity·2026

Comparison of Galleria mellonella, epithelial cell cytotoxicity, and mouse model of bacteremia to measure Pseudomonas aeruginosa virulence.

Infection and immunity·2026

Transcriptional analyses of peripheral blood lymphocytes obtained shortly after primary immunization discriminate vaccines against Francisella tularensis.

Infection and immunity·2026

HDAC6 inhibition reduces Pseudomonas aeruginosa adherence and internalization in cystic fibrosis epithelial cells via microtubule stabilization.

Infection and immunity·2026

Growing Staphylococcus aureus in synthetic cystic fibrosis medium promotes colonization in a murine pneumonia model.

Infection and immunity·2026

Early enhanced control of Plasmodium yoelii infection in IL-10-deficient mice is independent of IFN-γ, IL-12, and the humoral response.

Infection and immunity·2026

Linear IgA Bullous Dermatosis: A Rare Immune-Related Cutaneous Adverse Event Due to Pembrolizumab.

Cureus·2026

Short-Term Intensive Insulin Therapy as a Remission Induction Strategy in Newly Diagnosed Type 2 Diabetes Mellitus: A Systematic Review.

Cureus·2026

Targeting Human Immunodeficiency Virus Integrase Beyond the Active Site: The Discovery and Development of Allosteric Integrase Inhibitors.

ChemMedChem·2026

Invariant chain controls HLA-DQ folding and shapes the HLA class II proxiome.

Journal of immunology (Baltimore, Md. : 1950)·2026

Ultrasound-responsive PLGA nanoparticles co-loaded with celecoxib and catalase enhance the therapeutic efficacy of imatinib in gastrointestinal stromal tumors.

International journal of pharmaceutics·2026

Machine Learning-Guided Personalized Immunochemotherapy Strategies in Intrahepatic Cholangiocarcinoma.

JHEP reports : innovation in hepatology·2026

Related Experiment Videos

Mucosal immunization with a genetically engineered pertussis toxin S1 fragment-cholera toxin subunit B chimeric

Related Concept Videos

"As soon as it's trying to be persuasive, my skepticism kicks in": A qualitative study to co-design vaccine communication strategies with vaccine hesitant adults in Canada.

Safety and immunogenicity of one or two doses of the rVSVΔG-ZEBOV-GP Ebola virus vaccine in adults and adolescents living with HIV: a phase 2, multicentre, double-blind, randomised, placebo-controlled trial.

A controlled human infection model for symptomatic pertussis in North America using the pertactin-producing clinical isolate D420.

Epidemiology and severity of pediatric influenza hospitalizations before and during the COVID-19 pandemic: a surveillance study of the Canadian immunization monitoring program (IMPACT), 2012-2023.

Safety and immunogenicity of a booster dose of COVAC-2, a Sepivac SWE™ adjuvanted SARS-CoV-2 recombinant protein vaccine in previously vaccinated healthy adults; a randomized controlled multicentre trial.

Relative efficacy, safety, and immunogenicity analysis of two doses versus one dose of recombinant coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomized, double blinded phase 3 trial.

What goes around comes around: updates in the study of Coxiella burnetii lipopolysaccharide phase variation.

Comparison of Galleria mellonella, epithelial cell cytotoxicity, and mouse model of bacteremia to measure Pseudomonas aeruginosa virulence.

Transcriptional analyses of peripheral blood lymphocytes obtained shortly after primary immunization discriminate vaccines against Francisella tularensis.

HDAC6 inhibition reduces Pseudomonas aeruginosa adherence and internalization in cystic fibrosis epithelial cells via microtubule stabilization.

Growing Staphylococcus aureus in synthetic cystic fibrosis medium promotes colonization in a murine pneumonia model.

Early enhanced control of Plasmodium yoelii infection in IL-10-deficient mice is independent of IFN-γ, IL-12, and the humoral response.

Linear IgA Bullous Dermatosis: A Rare Immune-Related Cutaneous Adverse Event Due to Pembrolizumab.

Short-Term Intensive Insulin Therapy as a Remission Induction Strategy in Newly Diagnosed Type 2 Diabetes Mellitus: A Systematic Review.

Targeting Human Immunodeficiency Virus Integrase Beyond the Active Site: The Discovery and Development of Allosteric Integrase Inhibitors.

Invariant chain controls HLA-DQ folding and shapes the HLA class II proxiome.

Ultrasound-responsive PLGA nanoparticles co-loaded with celecoxib and catalase enhance the therapeutic efficacy of imatinib in gastrointestinal stromal tumors.

Machine Learning-Guided Personalized Immunochemotherapy Strategies in Intrahepatic Cholangiocarcinoma.

Related Experiment Videos

Mucosal immunization with a genetically engineered pertussis toxin S1 fragment-cholera toxin subunit B chimeric...

Abstract:

Related Concept Videos

Related Articles

Mucosal immunization with a genetically engineered pertussis toxin S1 fragment-cholera toxin subunit B chimeric